Newstral
Article
The Wichita Eagle on 2018-03-27 08:57
Novartis sells joint venture stake to GSK for $13 billion
Related news
- Novartis sells joint venture stake to GSK for $13 billionsanluisobispo.com
- Swiss pharma Novartis sells stake in joint venture to GSK for $13bnthelocal.ch
- FNovartis sells stake in joint venture to GSK for $13bnft.com
- WGSK, Novartis wrap up $21B asset swap, form joint venturewraltechwire.com
- Novartis sells stake in consumer business to GSK for $13bnbizjournals.com
- FNovartis sells stake in consumer unit to GSK for $13bnft.com
- Novartis sells consumer healthcare division to GSK in $13bn dealtimesofmalta.com
- FGSK to break up after striking Pfizer consumer joint ventureft.com
- NGSK, Pfizer team on over-the-counter drug joint venturenypost.com
- Pharmaceuticals sector: GSK sells off remaining stake in HaleonFinancial Times
- GSK sees drop in earnings after asset swap with Novartisreviewtimes.com
- BlackRock to Sell Stake in Indian Joint Venture to DSPwsj.com
- HLubrizol Corp. to take majority stake in Indian joint venturehome.crainscleveland.com
- FGSK to sell Aspen stake for almost £574mft.com
- GSK buys out Novartis in $13 billion consumer healthcare shake-uptimesofmalta.com
- GSK completes transaction with Novartisabc3340.com